Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer
BioEssays · 2025-08 · 47 (8)
DOI: 10.1002/bies.70025 ↗At a glance
Übersichtsarbeit in BioEssays, published online on 2025-06-09. Written by Aleix Bayona-Feliu and 1 co-authors. Institution: Department of Genetics, Microbiology and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain. Major MEDLINE topics: Neoplasms, DNA Replication, Genomic Instability, Transcription, Genetic. Cited 12 times so far (Crossref); 107 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Genome instability (GIN) is a cell pathology linked to cancer promotion and tumor evolution. Transcription is an essential cellular process but also a potential source of DNA damage and GIN. Transcription‐replication conflicts (TRCs) are a predominant source of GIN, and defective TRC resolution may seriously compromise genome integrity. Importantly, chromatin dynamics helps orchestrate the response to TRCs to preserve genome integrity. Multiple epigenetic deficiencies have been shown to cause transcription‐induced replication stress, resulting in DNA breaks and mutations. Consistently, chromatin alterations are frequent in cancer and correlate with increased mutation burden at TRC sites in tumors. Here, we review our current knowledge of TRC processing, the consequences of its dysfunction, and its relevance in cancer. We focus on the interplay between the DNA damage response (DDR) and chromatin dynamics and discuss the clinical potential of targeting TRCs as anticancer strategies and drugging the associated epigenetic signatures.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Genetics, Microbiology and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.
- Centro Andaluz de Biología Molecular y Medicina Regenerativa CABIMER, Universidad de Sevilla, Seville, Spain.
- Departamento de Genética, Facultad de Biología, Universidad de Sevilla, Seville, Spain.
ORCID profiles: Aleix Bayona-Feliu, Andrés Aguilera
Cite
APA
Bayona-Feliu, A., & Aguilera, A. (2025). Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer. BioEssays, 47(8). https://doi.org/10.1002/bies.70025
Vancouver
Bayona-Feliu A, Aguilera A. Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer. BioEssays. 2025;47(8). doi:10.1002/bies.70025
BibTeX
@article{BayonaFeliu2025,
author = {Bayona-Feliu, Aleix and Aguilera, Andrés},
title = {Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer},
journal = {BioEssays},
year = {2025},
volume = {47},
number = {8},
doi = {10.1002/bies.70025}
}
EUVIMED